ACUTE-PHASE EFFICACY OF ZS-9 IN PATIENTS WITH BASELINE SERUM POTASSIUM LEVELS ABOVE 5.5 MEQ/L: ANALYSIS FROM A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL

Severe hyperkalemia may be associated with cardiac arrhythmias and often requires emergent intervention including hemodialysis. Sodium zirconium cyclosilicate (ZS-9) is a nonabsorbed cation exchanger designed to specifically trap excess K+ in the gut. Here we report acute-phase efficacy in patients